Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Understanding the Differential Response of Setaria viridis L. (green foxtail) and Setaria pumila Poir. (yellow foxtail) to Pyroxsulam.

Satchivi NM, deBoer GJ, Bell JL.

J Agric Food Chem. 2017 Aug 30;65(34):7328-7336. doi: 10.1021/acs.jafc.7b01453. Epub 2017 Aug 17.

PMID:
28771349
2.

Pro-insecticidal approach towards increasing in planta activity.

Creemer LC, Giampietro NC, Lambert W, Yap MC, deBoer GJ, Adelfinskaya Y, Castetter S, Wessels FJ.

Pest Manag Sci. 2017 Apr;73(4):752-760. doi: 10.1002/ps.4358. Epub 2016 Aug 25.

PMID:
27414472
3.

Mevalocidin: a novel, phloem mobile phytotoxin from Fusarium DA056446 and Rosellinia DA092917.

Gerwick BC, Brewster WK, Deboer GJ, Fields SC, Graupner PR, Hahn DR, Pearce CJ, Schmitzer PR, Webster JD.

J Chem Ecol. 2013 Feb;39(2):253-61. doi: 10.1007/s10886-013-0238-7. Epub 2013 Jan 13.

PMID:
23314893
4.

The use of the CTrachâ„¢ Laryngeal Mask Airway in pediatric patients: a retrospective review of 25 cases.

Maurtua MA, Finnegan PS, Deboer G.

Can J Anaesth. 2011 Apr;58(4):409-10. doi: 10.1007/s12630-011-9456-z. Epub 2011 Feb 1. No abstract available.

PMID:
21286949
5.

Discovery and characterization of sulfoxaflor, a novel insecticide targeting sap-feeding pests.

Zhu Y, Loso MR, Watson GB, Sparks TC, Rogers RB, Huang JX, Gerwick BC, Babcock JM, Kelley D, Hegde VB, Nugent BM, Renga JM, Denholm I, Gorman K, DeBoer GJ, Hasler J, Meade T, Thomas JD.

J Agric Food Chem. 2011 Apr 13;59(7):2950-7. doi: 10.1021/jf102765x. Epub 2010 Nov 24.

PMID:
21105655
6.

The impact of uptake, translocation and metabolism on the differential selectivity between blackgrass and wheat for the herbicide pyroxsulam.

DeBoer GJ, Thornburgh S, Gilbert J, Gast RE.

Pest Manag Sci. 2011 Mar;67(3):279-86. doi: 10.1002/ps.2062. Epub 2010 Nov 22.

PMID:
21104793
7.

Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response.

Wong NS, Buckman RA, Clemons M, Verma S, Dent S, Trudeau ME, Roche K, Ebos J, Kerbel R, Deboer GE, Sutherland DJ, Emmenegger U, Slingerland J, Gardner S, Pritchard KI.

J Clin Oncol. 2010 Feb 10;28(5):723-30. doi: 10.1200/JCO.2009.24.0143. Epub 2009 Dec 21.

PMID:
20026801
8.

Anesthetic management of an obstetric patient with MELAS syndrome: case report and literature review.

Maurtua M, Torres A, Ibarra V, DeBoer G, Dolak J.

Int J Obstet Anesth. 2008 Oct;17(4):370-3. doi: 10.1016/j.ijoa.2007.11.011. Epub 2008 Aug 8.

PMID:
18691868
9.

Systemic properties of myclobutanil in soybean plants, affecting control of Asian soybean rust (Phakopsora pachyrhizi).

Kemmitt GM, DeBoer G, Ouimette D, Iamauti M.

Pest Manag Sci. 2008 Dec;64(12):1285-93. doi: 10.1002/ps.1630.

PMID:
18683908
10.

A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus.

Kassam Z, Wong RK, Ringash J, Ung Y, Kamra J, DeBoer G, O'Brien M, Kim J, Loblaw DA, Wong S, Cummings B, Davey P.

Clin Oncol (R Coll Radiol). 2008 Feb;20(1):53-60.

PMID:
18345545
11.

Ab initio energies and product branching ratios for the O+C3H6 reaction.

DeBoer GD, Dodd JA.

J Phys Chem A. 2007 Dec 20;111(50):12977-84. Epub 2007 Nov 14.

PMID:
17999472
12.
13.
14.

Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy.

Pearce A, Choo R, Danjoux C, Morton G, Loblaw DA, Szumacher E, Cheung P, Deboer G, Chander S.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):78-83. Epub 2006 Mar 24.

PMID:
16563657
15.

Uptake, translocation and metabolism of the herbicide florasulam in wheat and broadleaf weeds.

deBoer GJ, Thornburgh S, Ehr RJ.

Pest Manag Sci. 2006 Apr;62(4):316-24.

PMID:
16506146
16.

Effect of androgen suppression on hemoglobin in prostate cancer patients undergoing salvage radiotherapy plus 2-year buserelin acetate for rising PSA after surgery.

Chander S, Choo R, Danjoux C, Morton G, Pearse A, Deboer G, Szumacher E, Loblaw A, Cheung P, Woo T.

Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):719-24.

PMID:
15936551
17.

Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer.

Cheung P, Sixel K, Morton G, Loblaw DA, Tirona R, Pang G, Choo R, Szumacher E, Deboer G, Pignol JP.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):418-25.

PMID:
15890583
18.

Treatment of bone metastases with palliative radiotherapy: patients' treatment preferences.

Szumacher E, Llewellyn-Thomas H, Franssen E, Chow E, DeBoer G, Danjoux C, Hayter C, Barnes E, Andersson L.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1473-81.

PMID:
15817353
19.

How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients?

Choo R, Chander S, Danjoux C, Morton G, Pearce A, Deboer G, Szumacher E, Loblaw A, Cheung P, Woo T.

Can J Urol. 2005 Feb;12(1):2547-52.

PMID:
15777493
20.

Limited efficacy of salvage radiotherapy for biopsy confirmed or clinically palpable local recurrence of prostate carcinoma after surgery.

Choo R, Morton G, Danjoux C, Hong E, Szumacher E, DeBoer G.

Radiother Oncol. 2005 Feb;74(2):163-7. Epub 2004 Dec 15.

PMID:
15734204
21.

Metabolic acidosis due to propofol infusion.

Farag E, Deboer G, Cohen BH, Niezgoda J.

Anesthesiology. 2005 Mar;102(3):697-8; author reply 698-9. No abstract available.

PMID:
15731621
22.

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, Meschino WS, Piron CA, Narod SA.

JAMA. 2004 Sep 15;292(11):1317-25.

PMID:
15367553
23.
24.

Comparison of histologic grade between initial and follow-up biopsy in untreated, low to intermediate grade, localized prostate cancer.

Choo R, Do V, Sugar L, Klotz L, Bahk E, Hong E, Danjoux C, Morton G, DeBoer G.

Can J Urol. 2004 Feb;11(1):2118-24.

PMID:
15003150
25.

Symptom control and palliative care content of abstracts presented at the Canadian Association of Radiation Oncologists annual meetings.

Barnes EA, DeBoer G, Chow E.

Support Care Cancer. 2004 Feb;12(2):91-4. Epub 2003 Dec 4.

PMID:
14655042
26.

Is there a progression of histologic grade from radical prostatectomy to local recurrence in patients with clinically isolated local recurrence following surgery?

Choo R, Sugar L, Hong E, Mackenzie K, DeBoer G, Danjoux C, Morton G, Klotz L.

Can J Urol. 2003 Oct;10(5):1981-5.

PMID:
14633325
27.

The effect of craniotomy location on postoperative pain and nausea.

Irefin SA, Schubert A, Bloomfield EL, DeBoer GE, Mascha EJ, Ebrahim ZY.

J Anesth. 2003;17(4):227-31.

PMID:
14625709
28.

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma.

Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, Filmus J.

Gastroenterology. 2003 Jul;125(1):89-97.

PMID:
12851874
29.
30.

The anesthetic management of ventricular septal defect (VSD) repair in a child with mitochondrial cytopathy.

Farag E, Argalious M, Narouze S, DeBoer GE, Tome J.

Can J Anaesth. 2002 Nov;49(9):958-62.

PMID:
12419725
31.

Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation.

Bunting PS, DeBoer G, Choo R, Danjoux C, Klotz L, Fleshner N.

Clin Biochem. 2002 Sep;35(6):471-5.

PMID:
12413608
32.

Urodynamic findings 3 months after radiotherapy in patients treated with conformal external beam radiotherapy for prostate carcinoma.

Do V, Choo R, Deboer G, Herschorn S, Danjoux C, Chen CH, Barak I.

BJU Int. 2002 Jul;90(1):62-7.

33.

Urodynamic changes at 18 months post-therapy in patients treated with external beam radiotherapy for prostate carcinoma.

Choo R, Do V, Herschorn S, DeBoer G, Danjoux C, Morton G, Cheng CH, Barak I, Preiner J.

Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):290-6.

PMID:
12023132
34.

(IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy.

Choo R, Hruby G, Hong J, Bahk E, Hong E, Danjoux C, Morton G, DeBoer G.

Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):269-76.

PMID:
12023129
35.
36.
37.

Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?

Choo R, Hruby G, Hong J, Hong E, DeBoer G, Danjoux C, Morton G, Klotz L, Bhak E, Flavin A.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):674-80.

PMID:
11849789
38.

PSA doubling time of prostate carcinoma managed with watchful observation alone.

Choo R, DeBoer G, Klotz L, Danjoux C, Morton GC, Rakovitch E, Fleshner N, Bunting P, Kapusta L, Hruby G.

Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):615-20.

PMID:
11395227
39.

The role of serial transrectal ultrasonography in a 'watchful waiting' protocol for men with localized prostate cancer.

Hruby G, Choo R, Klotz L, Danjoux C, Murphy J, Deboer G, Morton G, Rakovitch E, Szumacher E, Fleshner N.

BJU Int. 2001 May;87(7):643-7.

40.

Coronary spasm and cardiac arrest from carcinoid crisis during laser bronchoscopy.

Mehta AC, Rafanan AL, Bulkley R, Walsh M, DeBoer GE.

Chest. 1999 Feb;115(2):598-600.

PMID:
10027471
41.

Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras.

Catzavelos C, Tsao MS, DeBoer G, Bhattacharya N, Shepherd FA, Slingerland JM.

Cancer Res. 1999 Feb 1;59(3):684-8.

42.

MYCN protein expression as a predictor of neuroblastoma prognosis.

Chan HS, Gallie BL, DeBoer G, Haddad G, Ikegaki N, Dimitroulakos J, Yeger H, Ling V.

Clin Cancer Res. 1997 Oct;3(10):1699-706.

43.

Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.

Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM.

Cancer Res. 1998 Feb 1;58(3):542-8.

44.

P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy.

Chan HS, Grogan TM, Haddad G, DeBoer G, Ling V.

J Natl Cancer Inst. 1997 Nov 19;89(22):1706-15.

PMID:
9390540
45.
46.

An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer.

Crump M, Sawka CA, DeBoer G, Buchanan RB, Ingle JN, Forbes J, Meakin JW, Shelley W, Pritchard KI.

Breast Cancer Res Treat. 1997 Jul;44(3):201-10.

PMID:
9266099
47.

Survey of consecutive prostate cancer patients attending the Toronto Sunnybrook Regional Cancer Centre (TSRCC).

Danjoux CE, DeBoer G, Choo RC, Iscoe NA, Morton GC, Young CS, Bjarnason GA, Klotz LH.

Can J Urol. 1996 Nov;3(4):268-276.

PMID:
12741961
48.

Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy.

Gallie BL, Budning A, DeBoer G, Thiessen JJ, Koren G, Verjee Z, Ling V, Chan HS.

Arch Ophthalmol. 1996 Nov;114(11):1321-8. Erratum in: Arch Ophthalmol 1997 Apr;115(4):525.

PMID:
8906022
49.

Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation.

Chan HS, DeBoer G, Thiessen JJ, Budning A, Kingston JE, O'Brien JM, Koren G, Giesbrecht E, Haddad G, Verjee Z, Hungerford JL, Ling V, Gallie BL.

Clin Cancer Res. 1996 Sep;2(9):1499-508.

50.

Effect of cranial surgery and brain tumor size on emergence from anesthesia.

Schubert A, Mascha EJ, Bloomfield EL, DeBoer GE, Gupta MK, Ebrahim ZY.

Anesthesiology. 1996 Sep;85(3):513-21.

PMID:
8853081

Supplemental Content

Loading ...
Support Center